Exelixis Inc Interest Expense
Exelixis Inc (EXEL) reported Interest Expense of $0 for the 12-month period ending 2020-01-03, per its 10-K filed 2020-02-25.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2020-02-25
- Exelixis Inc interest expense for the quarter ending 2018-12-28 was -$1.00K.
- Exelixis Inc interest expense for the quarter ending 2018-09-28 was $1.00K.
- Exelixis Inc interest expense for the quarter ending 2018-06-29 was $0.00, a 100.00% decline year-over-year.
- Exelixis Inc interest expense for the quarter ending 2018-03-30 was $0.00, a 100.00% decline year-over-year.
- Exelixis Inc interest expense for fiscal 2020 was $0.00.
- Exelixis Inc interest expense for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- Exelixis Inc interest expense for fiscal 2017 was $8.68M, a 73.75% decline from fiscal 2016.
- Exelixis Inc interest expense for fiscal 2016 was $33.06M.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-01-03 | $0.00 10-K · filed 2020-02-25 | |||||||
| 2018-12-28 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | $0.00 derived: sum of 3 quarters · filed 2020-02-25 | $0.00 10-K · filed 2020-02-25 | ||||
| 2018-09-28 | $1.00K 10-Q · filed 2018-11-01 | $1.00K derived: sum of 2 quarters · filed 2018-11-01 | $1.00K 10-Q · filed 2018-11-01 | $1.00K derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-06-29 | $0.00 10-Q · filed 2018-08-01 | $0.00 10-Q · filed 2018-08-01 | $0.00 derived: sum of 3 quarters · filed 2020-02-25 | $0.00 derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-03-30 | $0.00 10-Q · filed 2018-05-02 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | $0.00 derived: sum of 3 quarters · filed 2020-02-25 | |||||
| 2017-12-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | $8.68M 10-K · filed 2020-02-25 | |||||
| 2017-09-30 | $0.00 10-Q · filed 2017-11-01 | $8.68M 10-Q · filed 2017-11-01 | ||||||
| 2017-09-29 | $0.00 10-Q · filed 2018-11-01 | $4.26M derived: sum of 2 quarters · filed 2018-11-01 | $8.68M 10-Q · filed 2018-11-01 | $13.16M derived: sum of 4 quarters · filed 2018-11-01 | ||||
| 2017-06-30 | $4.26M 10-Q · filed 2018-08-01 | $8.68M 10-Q · filed 2017-08-02 | $13.16M derived: sum of 3 quarters · filed 2018-08-01 | $21.00M derived: sum of 4 quarters · filed 2018-08-01 | ||||
| 2017-03-31 | $4.42M 10-Q · filed 2017-05-01 | $8.90M derived: sum of 2 quarters · filed 2018-05-02 | $16.74M derived: sum of 3 quarters · filed 2018-05-02 | $27.19M derived: sum of 4 quarters · filed 2018-05-02 | ||||
| 2016-12-31 | $4.49M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $12.32M derived: sum of 2 quarters · filed 2017-11-01 | $22.77M derived: sum of 3 quarters · filed 2017-11-01 | $33.06M 10-K · filed 2017-02-27 | ||||
| 2016-12-30 | $33.06M 10-K · filed 2019-02-22 | |||||||
| 2016-09-30 | $7.83M 10-Q · filed 2017-11-01 | $18.29M derived: sum of 2 quarters · filed 2017-11-01 | $28.57M 10-Q · filed 2017-11-01 | $38.75M derived: sum of 4 quarters · filed 2017-11-01 | ||||
| 2016-06-30 | $10.45M 10-Q · filed 2017-08-02 | $12.63M 10-Q · filed 2016-08-03 | $20.74M 10-Q · filed 2017-08-02 | $25.04M 10-Q · filed 2016-08-03 | $30.92M derived: sum of 3 quarters · filed 2017-08-02 | $40.96M derived: sum of 4 quarters · filed 2017-08-02 | ||
| 2016-03-31 | $10.29M 10-Q · filed 2017-05-01 | $12.41M 10-Q · filed 2016-05-04 | $20.47M derived: sum of 2 quarters · filed 2017-05-01 | $30.51M derived: sum of 3 quarters · filed 2017-05-01 | $42.47M derived: sum of 4 quarters · filed 2017-05-01 | |||
| 2016-01-01 | $40.68M 10-K · filed 2018-02-26 | |||||||
| 2015-12-31 | $10.18M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $20.22M derived: sum of 2 quarters · filed 2017-02-27 | $32.17M derived: sum of 3 quarters · filed 2017-02-27 | $40.68M 10-K · filed 2017-02-27 | $48.67M 10-K · filed 2016-02-29 | |||
| 2015-09-30 | $10.04M 10-Q · filed 2016-11-03 | $12.06M 10-Q · filed 2015-11-10 | $22.00M derived: sum of 2 quarters · filed 2016-11-03 | $30.50M 10-Q · filed 2016-11-03 | $36.42M 10-Q · filed 2015-11-10 | $39.64M derived: sum of 4 quarters · filed 2017-02-27 | ||
| 2015-06-30 | $11.96M 10-Q · filed 2016-08-03 | $24.36M 10-Q · filed 2016-08-03 | $29.60M derived: sum of 3 quarters · filed 2017-02-27 | $41.88M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $12.40M 10-Q · filed 2016-05-04 | $17.64M derived: sum of 2 quarters · filed 2017-02-27 | $29.92M derived: sum of 3 quarters · filed 2017-02-27 | $42.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $5.24M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $17.52M derived: sum of 2 quarters · filed 2017-02-27 | $29.60M derived: sum of 3 quarters · filed 2017-02-27 | $41.36M 10-K · filed 2017-02-27 | $48.61M 10-K · filed 2015-03-02 | |||
| 2014-09-30 | $12.28M 10-Q · filed 2015-11-10 | $24.36M derived: sum of 2 quarters · filed 2015-11-10 | $36.13M 10-Q · filed 2015-11-10 | $41.18M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-06-30 | $12.08M 10-Q · filed 2015-08-11 | $23.84M 10-Q · filed 2015-08-11 | $28.90M derived: sum of 3 quarters · filed 2017-02-27 | $40.33M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-03-31 | $11.76M 10-Q · filed 2015-04-30 | $16.82M derived: sum of 2 quarters · filed 2017-02-27 | $28.25M derived: sum of 3 quarters · filed 2017-02-27 | $39.48M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2013-12-31 | $5.05M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $16.48M derived: sum of 2 quarters · filed 2017-02-27 | $27.72M derived: sum of 3 quarters · filed 2017-02-27 | $38.78M 10-K · filed 2017-02-27 | $45.35M 10-K · filed 2014-02-20 | |||
| 2013-09-30 | $11.43M 10-Q · filed 2014-11-04 | $22.67M derived: sum of 2 quarters · filed 2014-11-04 | $33.73M 10-Q · filed 2014-11-04 | $42.73M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2013-06-30 | $11.24M 10-Q · filed 2014-07-31 | $22.30M 10-Q · filed 2014-07-31 | $31.30M derived: sum of 3 quarters · filed 2017-02-27 | $38.98M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2013-03-31 | $11.06M 10-Q · filed 2014-05-01 | $20.06M derived: sum of 2 quarters · filed 2017-02-27 | $27.74M derived: sum of 3 quarters · filed 2017-02-27 | $31.83M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2012-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $16.68M derived: sum of 2 quarters · filed 2017-02-27 | $20.77M derived: sum of 3 quarters · filed 2017-02-27 | $24.78M 10-K · filed 2017-02-27 | $27.09M 10-K · filed 2013-02-21 | |||
| 2012-09-30 | $7.68M 10-Q · filed 2013-10-30 | $11.77M derived: sum of 2 quarters · filed 2013-10-30 | $15.78M 10-Q · filed 2013-10-30 | $19.79M derived: sum of 4 quarters · filed 2014-02-20 | ||||
| 2012-06-30 | $4.09M 10-Q · filed 2013-08-06 | $8.10M 10-Q · filed 2013-08-06 | $12.11M derived: sum of 3 quarters · filed 2014-02-20 | $16.25M derived: sum of 4 quarters · filed 2014-02-20 | ||||
| 2012-03-31 | $4.00M 10-Q · filed 2013-05-07 | $8.01M derived: sum of 2 quarters · filed 2014-02-20 | $12.16M derived: sum of 3 quarters · filed 2014-02-20 | $16.32M derived: sum of 4 quarters · filed 2014-02-20 | ||||
| 2011-12-31 | $4.01M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $8.15M derived: sum of 2 quarters · filed 2014-02-20 | $12.32M derived: sum of 3 quarters · filed 2014-02-20 | $16.26M 10-K · filed 2014-02-20 | ||||
| 2011-09-30 | $4.14M 10-Q · filed 2012-11-07 | $8.31M derived: sum of 2 quarters · filed 2012-11-07 | $12.25M 10-Q · filed 2012-11-07 | $16.21M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-06-30 | $4.16M 10-Q · filed 2012-08-02 | $8.11M 10-Q · filed 2012-08-02 | $12.07M derived: sum of 3 quarters · filed 2013-02-21 | $16.16M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-03-31 | $3.94M 10-Q · filed 2012-05-03 | $7.91M derived: sum of 2 quarters · filed 2013-02-21 | $12.00M derived: sum of 3 quarters · filed 2013-02-21 | $12.67M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2010-12-31 | $3.96M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $8.06M derived: sum of 2 quarters · filed 2013-02-21 | $8.73M derived: sum of 3 quarters · filed 2013-02-21 | $9.34M 10-K · filed 2013-02-21 | ||||
| 2010-09-30 | $4.09M 10-Q · filed 2011-10-27 | $4.77M derived: sum of 2 quarters · filed 2011-10-27 | $5.38M 10-Q · filed 2011-10-27 | |||||
| 2010-06-30 | $673.00K 10-Q · filed 2011-08-04 | $1.28M 10-Q · filed 2011-08-04 | ||||||
| 2009-12-31 | $12.67M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |